215 related articles for article (PubMed ID: 15459890)
1. Frog intestinal sac: a new in vitro method for the assessment of intestinal permeability.
Trapani G; Franco M; Trapani A; Lopedota A; Latrofa A; Gallucci E; Micelli S; Liso G
J Pharm Sci; 2004 Dec; 93(12):2909-19. PubMed ID: 15459890
[TBL] [Abstract][Full Text] [Related]
2. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
[TBL] [Abstract][Full Text] [Related]
3. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.
Da Silva LC; Da Silva TL; Antunes AH; Rezende KR
J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability.
Zakeri-Milani P; Barzegar-Jalali M; Azimi M; Valizadeh H
Eur J Pharm Biopharm; 2009 Sep; 73(1):102-6. PubMed ID: 19442726
[TBL] [Abstract][Full Text] [Related]
5. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
[TBL] [Abstract][Full Text] [Related]
6. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability.
Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
Int J Pharm; 2015 Jan; 478(2):736-44. PubMed ID: 25510602
[TBL] [Abstract][Full Text] [Related]
8. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique.
Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL
Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351
[TBL] [Abstract][Full Text] [Related]
11. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two approaches of intestinal absorption by puerarin.
Li H; Dong L; Liu Y; Wang G; Zhang L; Qiao Y
J Pharmacol Toxicol Methods; 2014; 70(1):6-11. PubMed ID: 24674709
[TBL] [Abstract][Full Text] [Related]
13. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
14. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches.
Lozoya-Agullo I; Zur M; Wolk O; Beig A; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A
Int J Pharm; 2015 Mar; 480(1-2):1-7. PubMed ID: 25595387
[TBL] [Abstract][Full Text] [Related]
15. Determination of lamivudine and zidovudine permeability using a different ex vivo method in Franz cells.
Dezani AB; Pereira TM; Caffaro AM; Reis JM; Serra CH
J Pharmacol Toxicol Methods; 2013; 67(3):194-202. PubMed ID: 23337245
[TBL] [Abstract][Full Text] [Related]
16. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
Zhang SY; Ong WSY; Subelzu N; Gleeson JP
Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
[TBL] [Abstract][Full Text] [Related]
17. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
18. Crystal-liquid Fugacity Ratio as a Surrogate Parameter for Intestinal Permeability.
Zakeri-Milani P; Fasihi Z; Akbari J; Jannatabadi E; Barzegar-Jalali M; Loebenberg R; Valizadeh H
J Pharm Pharm Sci; 2016; 19(3):312-324. PubMed ID: 27806246
[TBL] [Abstract][Full Text] [Related]
19. Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue.
Haslam IS; O'Reilly DA; Sherlock DJ; Kauser A; Womack C; Coleman T
Biopharm Drug Dispos; 2011 May; 32(4):210-21. PubMed ID: 21416475
[TBL] [Abstract][Full Text] [Related]
20. The utility of rat jejunal permeability for biopharmaceutics classification system.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]